5 results about "Berberis" patented technology

The application discloses a kind of resistance identification and system breeding method of excellent strain of anti-root rot Coptis, it is related to the technical field of medicinal plant disease resistance identification and strain breeding, the application is first according to pathogen composition, inoculation body preparation, seedling age, substrate treatment and environment window formation comparable batch group in seedling inoculation stage, resistance observation record generation group calibration processing result is introduced into the same batch of Coptis control strain, only allow comparable batch group to enter group screening in group calibration processing result is effective state. In this way, the resistance observation record that enters the same comparison chain meets the two prerequisites of consistent inoculation condition and batch response effective simultaneously, batches of inoculation failure, inoculation too strong, control loss or control deviation anomaly no longer directly enter group retention set, so that the disease level source of Coptis candidate strain is constrained to the same inoculation pressure and the same observation prerequisite, solve the problem that the disease level source of batches is inconsistent in front and back batches in multiple batches screening is directly combined and tabled.

This invention proposes a Bacillus berberis strain suitable for non-grain carbon sources and its fermentation method. This strain has strong stress resistance, nicotinamide metabolism characteristics, and the ability to produce active substances through tryptophan metabolism. It also has a stable preventive effect against tobacco red spot disease. This is of great significance for reducing the use of chemical pesticides, ensuring the quality and safety of tobacco leaves, and promoting the green and sustainable development of the tobacco industry.

The present application provides a traditional Chinese medicine composition for treating and / or preventing coronary heart disease, and a preparation method and application thereof. Specifically, the traditional Chinese medicine composition of the present application is prepared from raw materials comprising the following components: 8-13 parts of capillaris, 8-12 parts of atractylodes, 8-12 parts of alisma, 8-14 parts of curcuma, 10-20 parts of salvia, 8-14 parts of curcuma, 1-5 parts of panax notoginseng powder, 5-10 parts of rhizoma corydalis, 8-12 parts of pinellia, 5-10 parts of berberis, 4-10 parts of ginseng, 5-12 parts of dried tangerine or orange peel, and 4-10 parts of licorice. The present application also provides a method for preparing the traditional Chinese medicine composition of the present application and the use of the traditional Chinese medicine composition in preparing a medicine for treating and / or preventing coronary atherosclerotic heart disease. The traditional Chinese medicine composition of the present application can reduce blood viscosity, improve heart function, reduce myocardial infarction area, inhibit the formation of atherosclerotic plaques, regulate blood lipid levels, or reduce the level of myocardial injury markers in serum.

The application provides a traditional Chinese medicine compound for resisting uric acid nephropathy, and relates to the technical field of traditional Chinese medicine pharmacy. The traditional Chinese medicine compound is composed of curcuma longa, astragalus membranaceus, angelica sinensis, berberis wilsonii, corn silk, plantago seed, chicory, triplaridium chinense and smilax riparia. The traditional Chinese medicine compound is reasonably matched, and has the effects of clearing heat and removing dampness, removing blood stasis and discharging turbidity, benefiting qi and invigorating the spleen, dredging collaterals and protecting the kidney. The traditional Chinese medicine compound can target the pathological process of uric acid nephropathy and protect the kidney tissue structure in the animal level, can improve the kidney function of patients, relieve the symptoms and improve the cure rate in the clinic, is safe and has no adverse reactions, and provides an efficient and safe new scheme for the clinical treatment of uric acid nephropathy.

This invention provides a Burkholderia spp. bacterium, a synthetic bacterial community, and their application for the control of white rot disease in Coptis chinensis, belonging to the field of microbial technology. The Burkholderia spp. bacterium HJ23 has the preservation number CCTCC NO: M 20253076. This invention provides a synthetic bacterial community including Burkholderia spp. bacterium HJ23, Pseudomonas fluorescens, and Arthrobacter spp. This synthetic bacterial community can more effectively inhibit the growth of the pathogen causing white rot disease, controlling white rot in Coptis chinensis and peanuts. This synthetic bacterial community provides a novel and highly effective antagonistic strain resource for the green biological control of this soil-borne disease, and can effectively replace or reduce the use of chemical pesticides, reducing the risk of pesticide residues. This aligns with the development needs of green cultivation of Chinese medicinal herbs, and has significant practical value for ensuring the quality of Coptis chinensis, improving the economic benefits of Coptis chinensis cultivation, and promoting the sustainable development of the Coptis chinensis cultivation industry.